| Financial Year |
March 31 2023 |
| Monetary Funds |
13,538,459.40 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
77,746,070.67 |
| Advances to Suppliers |
1,916,283.74 |
| Other Receivables |
5,481,544.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,422,577.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,093,239.68 |
| Total Current Assets |
133,198,175.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
114,497,047.92 |
| Under-construction Projects |
76,893,880.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
154,026,699.49 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,375,449.57 |
| Deferred Income Tax Assets |
24,672,325.54 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
374,007,275.36 |
| Total Assets |
507,205,450.85 |
| Short-Term Loans |
825,410,482.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
64,237,938.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,144,207.67 |
| Taxes Payable |
4,990,468.10 |
| Interest Payable |
4,200.01 |
| Dividend Payable |
-- |
| Other payables |
165,269,954.01 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
552,574.34 |
| Other Current Liabilities |
216,707.05 |
| Sub-Total of Current Liabilities |
1,066,489,309.37 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
87,658,568.14 |
| Deferred Income Tax Liabilities |
24,896,610.47 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
121,021,415.71 |
| Total Liabilities |
1,187,510,725.08 |
| Paid-In Capital(Or Share Stock) |
537,989,106.00 |
| Capital Surplus |
1,127,988,697.93 |
| Surplus Reserve |
77,712,289.76 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,409,957,816.65 |
| Minority Stockholder's Interest |
-9,978,464.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-670,326,809.83 |
| Owner's Equity（Stockholder's Equity） |
-680,305,274.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
507,205,450.85 |
